Go to content Go to the menu Go to the search

PartnersSorbonne University
Quick access, personalized services
Search
INTERNATIONAL SCHOOL IBCD
Immunological Biotherapies: Concepts and Development

About IS-IBCD

With unprecedented technological advances and improvement of our knowledge in the pathophysiology of diseases, immunological biotherapies - such as immunotherapy, new vaccine strategies, cell and gene therapies - now represent innovative therapeutic strategies.

These new treatments, on their own or combine with conventional therapeutics, revolutionize the fields of applications in medicine with the development of more effective therapeutic approaches or personalized for patients.

That is why many pharmaceutical industries invest heavily in research and development biotherapies to propose new therapeutic products.

It is therefore necessary to provide a high level of training provided by the best specialists in the field.

This teaching will bring you an extensive knowledge on these new therapeutic tools, from their concept to their development to clinical trials, which will allow you to understand the challenges and problems of the new medical approaches, and promote your professional integration.

IS-IBCD is complementary to the Master international PIM “Biotherapies in Immunology” of Immunology speciality from BMC (Biologie moléculaire et Cellulaire), Faculté de Biologie at Université Pierre et Marie Curie in Paris.

Teaching program 2018

  • Module 1: Marchth 27 to 29th / Mechanisms of action of immunomodulatory agents
  • Module 2: April 24th to 26th / Cancer immunotherapy
  • Module 3 : May 15th to 17th / Immunotherapy of chronic inflammation
  • Module 4 : June 13th to 14th / Vaccine development in infectious diseases

More information about the program

Location

More information about IS-IBCD 2018

17/11/17

Traductions :

    Contact us

    Miriam MERAD 
    François LEMOINE
    Roger CHAMMAS
    Rachel Fabre -  Secretary
     
    ORGANIZERS : 
    Miriam Merad, MD, PhD, is a Professor of Oncological Science and of Medicine (Hem/Onc division) at the Icahn School of Medicine at Mount Sinai in New York.
    Dr. Merad’s laboratory studies the mechanisms that regulate the...

    » Read more